Titlebook: Renal Cancer; Current Status and I Christopher Anderson,Mehran Afshar Book 2022 Springer Nature Switzerland AG 2022 Endoscopic Surgery.Cogn

Hay-Fever

The Role of Ablative Therapies in Renal Cancer,ble oncological outcomes to traditional surgery. Percutaneous ablation techniques have been gaining popularity as they are less invasive, have fewer complications and cost less. Ablative therapies currently being used include cryoablation (CRA), radiofrequency ablation (RFA), microwave ablation (MWA

断断续续

Radical Nephrectomy for Renal Cell Carcinoma: Non-robotic Minimally Invasive Approaches,renal fat and Gerota’s fascia) in the 1960s given the demonstrated improvement in oncologic outcomes. Since the initial report in 1991, the laparoscopic approach to radical nephrectomy has been widely adopted for complete kidney removal given its improved post-operative recovery as compared to open

Vulvodynia

Radical Nephrectomy: Role of Robotic Assisted Approach,ours which are not amenable to partial nephrectomy, to more complex larger tumours which would previously be considered for open surgery. Robotics offers finer dexterity and magnification than a purely laparoscopic approach, as we have seen with robotic partial nephrectomy. While often considered mo

高贵领导

progestogen

BADGE

Transperitoneal Robotic Partial Nephrectomy,advantages of minimally invasive surgery (faster postoperative recovery, reduced blood loss, and postoperative pain) along with a wider range of movement, three-dimensional (3D) and magnified vision, and the camera controlled by the primary surgeon. The application of preoperative scoring systems im

哎呦

Lymph Node Dissection in Renal Cancer and Upper Tract Urothelial Cancer,ailable evidence is mainly retrospective, often of poor quality, and predates the era of effective systemic therapy. The lymphatic drainage from the kidneys is highly variable and LND templates are not standardised or defined. Lymph node involvement at the time of nephrectomy is usually associated w

织布机

Metamorphosis

鄙视

Metastatic Tumours: Cytoreductive Nephrectomy,tatic renal cell carcinoma. The evidence surrounding this controversial treatment is reviewed and other indications for nephrectomy are discussed. We discuss the complex issues surrounding patient selection and how this may be improved in the future to choose the appropriate case for CRN.